semaglutide approval mash Novo's Wegovy becomes first GLP-1 drug approved for health canada semaglutide Wegovy® (semaglutide

Individuals living in Central Florida can easily attend our treatment to achieve long-term recovery

Fat-Focused Weight Loss Clinical body-composition analyses show that retatrutide promotes greater fat mass loss with relative preservation of lean muscle, supporting healthier body recomposition rather than simple weight reduction

Use retatrutide within 28-60 days

Recent cohort and RCT research shows that adults receiving semaglutide or tirzepatide experience dramatic improvements in weight and health outcomes

Studies consistently show that approximately 30 to 40% of weight lost on GLP-1 agonists comes from lean tissue, primarily muscle